Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR

Molecular Endocrinology

Volumn 18, Issue 10, 2004, Pages 2502-2512

  Denley, Adam ^a,b   Bonython, Eric R ^a   Booker, Grant W ^a   Cosgrove, Leah J ^b   Forbes, Briony E ^a,b   Ward, Colin W ^b   Wallace, John C ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; ISOPROTEIN; SOMATOMEDIN B; SOMATOMEDIN C;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CANCER CELL; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; EXON; FETUS CELL; GENE EXPRESSION; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

3T3 CELLS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; EXONS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RECEPTOR, INSULIN; RECOMBINANT FUSION PROTEINS; RESTRICTION MAPPING; SEQUENCE DELETION;

ANIMALIA;

EID: 5044227353     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2004-0183     Document Type: Article

References (62)

1. Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR 2003 Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 111: 1835-1842
2. Entingh AJ, Taniguchi CM, Kahn CR 2003 Bi-directional regulation of brown fat adipogenesis by the insulin receptor. J Biol Chem 278:33377-33383
3. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339
4. Lauro D, Kido Y, Castle AL, Zamowski MJ, Hayashi H, Ebina Y, Accili D 1998 Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat Genet 20:294-298
5. Michael MD, Kulkarni RN, Postic C, Previs SS, Shulman GI, Magnuson MA, Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97
6. De Meyts P, Whittaker J 2002 Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 1:769-783
7. Sesti G 2000 Insulin receptor variant forms and type 2 diabetes mellitus. Pharmacogenomics 1:49-61
8. Sesti G, Federici M, Lauro D, Sbraccia P, Lauro R 2001 Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes Metab Res Rev 17:363-373
9. Seino S, Bell GI 1989 Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 159:312-316
10. McClain DA 1991 Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5:734-739
11. Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM, Moller DE 1991 Functional properties of two naturally occurring isoforms of the human insulin receptor jn Chinese hamster ovary cells. Endocrinology 129: 2058-2066
12. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288
13. Kellerer M, Lammers R, Ermel B, Tippmer S, Vogt B, Obermaier-Kusser B, Ullrich A, Haring HU 1992 Distinct α-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 31:4588-4596
14. Savkur RS, Philips AV, Cooper TA 2001 Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29:40-47
15. Vogt B, Carrascosa JM, Ermel B, Ullrich A, Haring HU 1991 The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun 177:1013-1018
16. Uhles S, Moede T, Leibiger B, Berggren PO, Leibiger IB 2003 Isoform-specific insulin receptor signaling involves different plasma membrane domains. J Cell Biol 163: 1327-1337
17. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkami RN, Kahn CR, de Vargas LM, Berggren PO 2001 Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol Cell 7:559-570
18. Sazani P, Kole R 2003 Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J Clin Invest 112:481-486
19. Denley A, Wallace JC, Cosgrove LJ, Forbes BE 2003 The insulin receptor isoform exon 11-(IR-A) in cancer and other diseases: a review. Horm Metab Res 35: 778-785
20. Louvi A, Accili D, Efstratiadis A 1997 Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 189:33-48
21. Morrione A, Valentinis B, Xu SQ, Yumet G, Louvi A, Efstratiadis A, Baserga R 1997 Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci USA 94:3777-3782
22. Sciacca L, Mineo R, Pandini G, Murabito A, Vigneri R, Belfiore A 2002 In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene 21:8240-8250
23. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta F 1996 Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271:11477-11483
24. Renehan AG, Jones J, Potten CS, Shalet SM, O'Dwyer ST 2000 Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer 83:1344-1350
25. Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton JP, Girard F, Le Bouc Y 1994 Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 78:1444-1453
26. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, Belfiore A 2002 A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 87:245-254
27. Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC, Conover CA 2002 Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endocrinology 143:3259-3267
28. Cooke RM, Harvey TS, Campbell ID 1991 Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry 30:5484-5491
29. Sato A, Nishimura S, Ohkubo T, Kyogoku Y, Koyama S, Kobayashi M, Yasuda T, Kobayashi Y 1993 Three-dimensional structure of human insulin-like growth factor-I (IGF-I) determined by 1H-NMR and distance geometry. Int J Pept Protein Res 41:433-440
30. Terasawa H, Kohda D, Hatanaka H, Nagata K, Higashihashi N, Fujiwara H, Sakano K, Inagaki F 1994 Solution structure of human insulin-like growth factor II; recognition sites for receptors and binding proteins. EMBO J 13:5590-5597
31. Torres AM, Forbes BE, Aplin SE, Wallace JC, Francis GL, Norton RS 1995 Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. J Mol Biol 248:385-401
32. Carrick FE, Forbes BE, Wallace JC 2001 BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains. J Biol Chem 276:27120-27128
33. Whittaker J, Sorensen H, Gadsboll VL, Hinrichsen J 2002 Comparison of the functional insulin binding epitopes of the A and B isoforms of the insulin receptor. J Biol Chem 277:47380-47384
34. Surinya KH, Molina L, Soos MA, Brandt J, Kristensen C, Siddle K 2002 Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies. J Biol Chem 277: 16718-16725
35. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA 1990 Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 9:2409-2413
36. Adams TE, Epa VC, Garrett TP, Ward CW 2000 Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093
37. Bayne ML, Applebaum J, Underwood D, Chicchi GG, Green BG, Hayes NS, Cascieri MA 1989 The C region of human insulin-like growth factor (IGF) I is required for high affinity binding to the type 1 IGF receptor. J Biol Chem 264:11004-11008
38. Bayne ML, Applebaum J, Chicchi GG, Miller RE, Cascieri MA 1990 The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J Biol Chem 265: 15648-15652
39. Hodgson DR, May FE, Westley BR 1996 Involvement of phenylalanine 23 in the binding of IGF-1 to the insulin and type I IGF receptor. Regul Pept 66:191-196
40. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-39695
41. Kurose T, Pashmforoush M, Yoshimasa Y, Carroll R, Schwartz GP, Burke GT, Katsoyannis PG, Steiner DF 1994 Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the α-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor. J Biol Chem 269: 29190-29197
42. Mynarcik DC, Yu GQ, Whittaker J 1996 Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor α subunit. J Biol Chem 271:2439-2442
43. Mynarcik DC, Williams PF, Schaffer L, Yu GQ, Whittaker J 1997 Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding. J Biol Chem 272:18650-18655
44. Brandt J, Andersen AS, Kristensen C 2001 Dimeric fragment of the insulin receptor α-subunit binds insulin with full holoreceptor affinity. J Biol Chem 276: 12378-12384
45. Kristensen C, Andersen AS, Ostergaard S, Hansen PH, Brandt J 2002 Functional reconstitution of insulin receptor binding site from non-binding receptor fragments. J Biol Chem 277:18340-18345
46. Brzozowski AM, Dodson EJ, Dodson GG, Murshudov GN, Verma C, Turkenburg JP, de Bree FM, Dauter Z 2002 Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry 41: 9389-9397
47. DiMarchi RD, Fan L, Long HB 1997 IGF-I superagonists. Indianapolis, IN: Eli Lilly and Company; 1-17 (U.S. Patent No. 5,622,932)
48. Kristensen C, Andersen AS, Hach M, Wiberg FC, Schaffer L, Kjeldsen T 1995 A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor. Biochem J 305:981-986
49. Chang SG, Kim DY, Choi KD, Shin JM, Shin HC 1998 Human insulin production from a novel mini-proinsulin which has high receptor-binding activity. Biochem J 329: 631-635
50. Pietrzkowski Z, Lammers R, Carpenter G, Soderquist AM, Limardo M, Phillips PD, Ullrich A, Baserga R 1992 Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ 3:199-205
51. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R 1994 Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612
52. King R, Wells JR, Krieg P, Snoswell M, Brazier J, Bagley CJ, Wallace CJ, Wallace JC, Ballard FJ, Ross M, Francis GL 1992 Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins. J Mol Endocrinol 8:29-41
53. Shooter GK, Magee B, Soos MA, Francis GL, Siddle K, Wallace JC 1996 Insulin-like growth factor (IGF)-I A- and B-domain analogues with altered type 1 IGF and insulin receptor binding specificities. J Mol Endocrinol 17: 237-246
54. Lien S, Milner SJ, Graham LD, Wallace JC, Francis GL 2001 Linkers for improved cleavage of fusion proteins with an engineered α-lytic protease. Biotechnol Bioeng 74:335-343
55. Milner SJ, Francis GL, Wallace JC, Magee BA, Ballard FJ 1995 Mutations in the B-domain of insulin-like growth factor-I influence the oxidative folding to yield products with modified biological properties. Biochem J 308: 865-871
56. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ 1986 Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45: 721-732
57. Hoyne PA, Cosgrove LJ, McKern NM, Bentley JD, Ivancic N, Elleman TC, Ward CW 2000 High affinity insulin binding by soluble insulin receptor extracellular domain fused to a leucine zipper. FEBS Lett 479:15-18
58. Hobbs S, Jitrapakdee S, Wallace JC 1998 Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1α promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 252:368-372
59. Mazor O, Hillairet de Boisferon M, Lombet A, Gruaz-Guyon A, Gayer B, Skrzydelsky D, Kohen F, Forgez P, Scherz A, Rostene W, Salomon Y 2002 Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies. Anal Biochem 301: 75-81
60. Soos MA, O'Brien RM, Brindle NP, Stigter JM, Okamoto AK, Whittaker J, Siddle K 1989 Monoclonal antibodies to the insulin receptor mimic metabolic effects of insulin but do not stimulate receptor autophosphorylation in transfected NIH 3T3 fibroblasts. Proc Natl Acad Sci USA 86:5217-5221
61. Soos MA, Field CE, Lammers R, Ullrich A, Zhang B, Roth RA, Andersen AS, Kjeldsen T, Siddle K 1992 A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity. J Biol Chem 267:12955-12963
62. Chen JW, Ledet T, Orskov H, Jessen N, Lund S, Whittaker J, De Meyts P, Larsen MB, Christiansen JS, Frystyk J 2003 A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 284:E1149-E1155